Guanidine-Containing Polyhydroxyl Macrolides: Chemistry, Biology, and Structure-Activity Relationship
Open Access
Abstract
Antimicrobial resistance has been seriously threatening human health, and discovering new antimicrobial agents from the natural resource is still an important pathway among various strategies to prevent resistance. Guanidine-containing polyhydroxyl macrolides, containing a polyhydroxyl lactone ring and a guanidyl side chain, can be produced by many actinomycetes and have been proved to possess many bioactivities, especially broad-spectrum antibacterial and antifungal activities. To explore the potential of these compounds to be developed into new antimicrobial agents, a review on their structural diversities, spectroscopic characterizations, bioactivities, acute toxicities, antimicrobial mechanisms, and the structure-activity relationship was first performed based on the summaries and analyses of related publications from 1959 to 2019. A total of 63 guanidine-containing polyhydroxyl macrolides were reported, including 46 prototype compounds isolated from 33 marine and terrestrial actinomycetes and 17 structural derivatives. Combining with their antimicrobial mechanisms, structure-activity relationship analyses indicated that the terminal guanidine group and lactone ring of these compounds are vital for their antibacterial and antifungal activities. Further, based on their bioactivities and toxicity analyses, the discovery of guanidyl side-chain targeting to lipoteichoic acid of Staphylococcus aureus indicated that these compounds have a great potency to be developed into antimicrobial and anti-inflammatory drugs.Keywords
Funding Information
- National Natural Science Foundation of China (81660578, 81960636 and 81460529)
This publication has 101 references indexed in Scilit:
- New Azalomycin F Analogs from Mangrove Streptomyces sp. 211726 with Activity against Microbes and Cancer CellsMarine Drugs, 2013
- Small molecule inhibitor of lipoteichoic acid synthesis is an antibiotic for Gram-positive bacteriaProceedings of the National Academy of Sciences, 2013
- The 10 × ‘20 Initiative: Pursuing a Global Commitment to Develop 10 New Antibacterial Drugs by 2020Clinical Infectious Diseases, 2010
- The wall teichoic acid and lipoteichoic acid polymers of Staphylococcus aureusInternational Journal of Medical Microbiology, 2010
- Synergistic combination of direct plasma membrane damage and oxidative stress as a cause of antifungal activity of polyol macrolide antibiotic niphimycinJournal of Bioscience and Bioengineering, 2002
- Malolactomycin D, a potent inhibitor of transcription controlled by the Ras responsive element, inhibits Ras-mediated transformation activity with suppression of MMP-1 and MMP-9 in NIH3T3 cellsOncogene, 2001
- Studies on macrocyclic lactone antibiotics. V. The structures of azalomycins F3a and F5a.Chemical and Pharmaceutical Bulletin, 1982
- Studies on macrocyclic lactone antibiotics. III. Skeletal structure of azalomycin F4a.Chemical and Pharmaceutical Bulletin, 1982
- Studies on macrocyclic lactone antibiotics. II. Partial structures of azalomycin F4a.Chemical and Pharmaceutical Bulletin, 1982
- Studies on macrocyclic lactone antibiotics. I. Physicochemical properties of azalomycin F4a.Chemical and Pharmaceutical Bulletin, 1982